111 related articles for article (PubMed ID: 12076710)
1. Fas-ligand and perforin expression in infiltrating cytotoxic T lymphocytes in the liver of chronic hepatitis C.
Ono K; Tanaka Y; Kusano F; Kakinuma S; Ishidate K; Watanabe M; Marumo F; Sato C
Hepatol Res; 2002 Jul; 23(3):153-162. PubMed ID: 12076710
[TBL] [Abstract][Full Text] [Related]
2. Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis.
Tagashira M; Yamamoto K; Fujio K; Nagano T; Okamoto R; Ibuki N; Yabushita K; Matsumura S; Okano N; Tsuji T
J Clin Immunol; 2000 Sep; 20(5):347-53. PubMed ID: 11051276
[TBL] [Abstract][Full Text] [Related]
3. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
Ando K; Hiroishi K; Kaneko T; Moriyama T; Muto Y; Kayagaki N; Yagita H; Okumura K; Imawari M
J Immunol; 1997 Jun; 158(11):5283-91. PubMed ID: 9164947
[TBL] [Abstract][Full Text] [Related]
4. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection.
Lee JY; Chae DW; Kim SM; Nam ES; Jang MK; Lee JH; Kim HY; Yoo JY
J Viral Hepat; 2004 Mar; 11(2):130-5. PubMed ID: 14996347
[TBL] [Abstract][Full Text] [Related]
5. Fas system and apoptosis in viral hepatitis.
Hayashi N; Mita E
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S223-6. PubMed ID: 9407341
[TBL] [Abstract][Full Text] [Related]
6. In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis.
Ibuki N; Yamamoto K; Yabushita K; Okano N; Okamoto R; Shimada N; Hakoda T; Mizuno M; Higashi T; Tsuji T
Liver; 2002 Jun; 22(3):198-204. PubMed ID: 12100569
[TBL] [Abstract][Full Text] [Related]
7. Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.
Hodgson PD; Grant MD; Michalak TI
Clin Exp Immunol; 1999 Oct; 118(1):63-70. PubMed ID: 10540161
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
[TBL] [Abstract][Full Text] [Related]
10. Distinct patterns of mucosal apoptosis in H pylori-associated gastric ulcer are associated with altered FasL and perforin cytotoxic pathways.
Souza HS; Neves MS; Elia CC; Tortori CJ; Dines I; Martinusso CA; Madi K; Andrade L; Castelo-Branco MT
World J Gastroenterol; 2006 Oct; 12(38):6133-41. PubMed ID: 17036384
[TBL] [Abstract][Full Text] [Related]
11. Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis.
Tordjmann T; Soulie A; Guettier C; Schmidt M; Berthou C; Beaugrand M; Sasportes M
Liver; 1998 Dec; 18(6):391-7. PubMed ID: 9869393
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
Roth E; Pircher H
J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
[TBL] [Abstract][Full Text] [Related]
13. Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.
Sharma VK; Bologa RM; Li B; Xu GP; Lagman M; Hiscock W; Mouradian J; Wang J; Serur D; Rao VK; Suthanthiran M
Transplantation; 1996 Dec; 62(12):1860-6. PubMed ID: 8990377
[TBL] [Abstract][Full Text] [Related]
14. Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage.
Ohshima K; Suzumiya J; Shimazaki K; Kato A; Tanaka T; Kanda M; Kikuchi M
Histopathology; 1997 Nov; 31(5):444-50. PubMed ID: 9416485
[TBL] [Abstract][Full Text] [Related]
15. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury.
Watanabe Y; Morita M; Akaike T
Hepatology; 1996 Sep; 24(3):702-10. PubMed ID: 8781346
[TBL] [Abstract][Full Text] [Related]
16. Perforin and Fas pathways of cytotoxic T-cells in histiocytic necrotizing lymphadenitis.
Ohshima K; Shimazaki K; Kume T; Suzumiya J; Kanda M; Kikuchi M
Histopathology; 1998 Nov; 33(5):471-8. PubMed ID: 9839173
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
Hishii M; Kurnick JT; Ramirez-Montagut T; Pandolfi F
Clin Exp Immunol; 1999 Jun; 116(3):388-94. PubMed ID: 10361224
[TBL] [Abstract][Full Text] [Related]
18. Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
Bachmann MF; Ohteki T; Faienza KM; Zakarian A; Kägi D; Speiser DE; Ohashi PS
J Immunol; 1997 Nov; 159(9):4165-70. PubMed ID: 9379009
[TBL] [Abstract][Full Text] [Related]
19. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
Melgar S; Bas A; Hammarström S; Hammarström ML
Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
[TBL] [Abstract][Full Text] [Related]
20. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
